Kelly Financial Services’s Amphastar Pharmaceuticals AMPH Stock Holding History
Bought
Maintained
Sold
Other funds holding AMPH
EIP
Kelly Financial Services's AMPH Position: Q3 2024 in Review
Kelly Financial Services sold out of Amphastar Pharmaceuticals (AMPH) in Q3 2024, closing a stake of 150 shares — an estimated $6K sold.
Kelly Financial Services first reported a position in AMPH in Q1 2019 and held it in 22 quarters. The position peaked at $9.28K in Q4 2023. 279 funds tracked by Wall St. Rank hold AMPH as of Q3 2024.
- Kelly Financial Services reported no remaining Amphastar Pharmaceuticals position as of Q3 2024 after selling out during the quarter.
- Kelly Financial Services sold 150 Amphastar Pharmaceuticals shares in Q3 2024, an estimated $6K.
- Kelly Financial Services first reported a position in Amphastar Pharmaceuticals in Q1 2019 and held it in 22 quarters.
- Kelly Financial Services's Amphastar Pharmaceuticals position peaked at $9.28K in Q4 2023.
- 279 funds tracked by Wall St. Rank held Amphastar Pharmaceuticals as of Q3 2024.
Based on Kelly Financial Services's 13F filing for Q3 2024, filed 9 Oct 2024.